Novo Nordisk

Troubling New Signals? Diabetes Drugs & Adverse Event Reports
Pharmalot
Thu, 04/18/13 - 10:43 am
adverse events
diabetes
FDA
Novo Nordisk
Bristol-Myers Squibb
Boehringer Ingelheim
Merck
Eli Lilly
Clean Superiority Sweep For Dulaglutide Could Reshape Diabetes Market
Seeking Alpha
Wed, 04/17/13 - 04:40 pm
diabetes
Eli Lilly
dulaglutide
Novo Nordisk
Sanofi
A Clouded Future For Big Pharma's Blockbuster Diabetes Drugs
Seeking Alpha
Wed, 04/3/13 - 10:48 am
diabetes
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
Novo Nordisk
Merck
Incretin
How Much Will FDA Action On Invokana Affect Johnson And Johnson's Revenue And Stock Price?
Seeking Alpha
Thu, 03/28/13 - 10:23 am
JNJ
FDA
Invokana
AstraZeneca
Bristol-Myers Squibb
Merck
Sanofi
Novo Nordisk
Novartis
4 Stocks Dragging The Drugs Industry Downward
TheStreet.com
Thu, 03/28/13 - 08:52 am
Novo Nordisk
Teva
Sanofi
Novartis
Novo Lures Sanofi Pitchman as Diabetes Battle Heats Up
Bloomberg
Wed, 03/27/13 - 10:26 am
Sanofi
Novo Nordisk
diabetes
Drug Manufacturing Stocks Tumble on FDA Concerns
Yahoo/Accesswire
Fri, 03/22/13 - 10:49 am
drug manufacturing
Depomed
Novo Nordisk
Novo Nordisk’s Oral Insulin Successfully Completes Early Study
Bloomberg
Wed, 03/20/13 - 11:54 am
insulin
Novo Nordisk
diabetes
Merrion
Novo Nordisk obesity drug results underwhelm investors
Reuters
Tue, 03/19/13 - 11:02 am
obesity
Novo Nordisk
liraglutide
Novo Nordisk hit by insulin drug doubts, downgrade
Marketwatch
Tue, 03/19/13 - 10:53 am
insulin
Novo Nordisk
Tresiba
Novo Nordisk Says Trial Shows Victoza Helps Patients Lose Weight
Bloomberg
Mon, 03/18/13 - 11:22 am
Novo Nordisk
Victoza
obesity
diabetes
4 Stocks Pushing The Health Care Sector Higher
The Street
Sat, 03/16/13 - 10:49 am
Novo Nordisk
Sanofi
Novartis
Alexion
Longer Lasting Drugs Make For Longer Lasting Profits
Seeking Alpha
Fri, 03/15/13 - 10:54 am
AntriaBio
AstraZeneca
Novo Nordisk
Sanofi
Bristol-Myers Squibb
Diabetes Drugs Are Being Evaluated for Pancreatic Risk
Bloomberg
Thu, 03/14/13 - 11:15 am
pancreatic cancer
diabetes
Merck
Januvia
Bristol-Myers Squibb
Byetta
Novo Nordisk
Victoza
U.S. rejection of Novo drug seen temporary but costly
Yahoo/Reuters
Thu, 02/21/13 - 12:03 pm
Novo Nordisk
Tresiba
diabetes
Sanofi advances after FDA delays rival insulin product
The Fly on the Wall
Mon, 02/11/13 - 11:07 am
FDA
insulin
Novo Nordisk
Sanofi
Tresiba
Lantus
Novo Nordisk hit hard as U.S. rebuffs insulin drug
Yahoo/Reuters
Mon, 02/11/13 - 08:15 am
insulin
Novo Nordisk
diabetes
FDA
Tresiba
Alas, Hamlet! A Diabetes Drugmaker to Renew the Faith
Motley Fool
Tue, 02/5/13 - 10:49 am
diabetes
Novo Nordisk
Danish drug maker Novo Nordisk in $1 billion net profit on strong sales of insulins
Yahoo/AP
Thu, 01/31/13 - 10:40 am
Novo Nordisk
earnings
Novo Nordisk A/S Reaches New 52-Week High (NVO)
The Street
Wed, 01/30/13 - 06:12 pm
Novo Nordisk
52 week high
stock

Pages